TP53 mutation appears to be an early event during SCLC evolution leading to gene instability and subsequent mutations in other tumour suppressor genes such as RB1, the most commonly mutated gene along with TP53 (co-mutation rate up to 90%) [9]. This evidence concerns the gene RB1 and small cell lung carcinoma.